QL ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
QL01 ANTINEOPLASTIC AGENTS
QL01E PROTEIN KINASE INHIBITORS
QL01EX Other protein kinase inhibitors
QL01EX01 sunitinib
QL01EX02 sorafenib
QL01EX03 pazopanib
QL01EX04 vandetanib
QL01EX05 regorafenib
QL01EX06 masitinib
QL01EX07 cabozantinib
QL01EX08 lenvatinib
QL01EX09 nintedanib
QL01EX10 midostaurin
QL01EX11 quizartinib
QL01EX12 larotrectinib
QL01EX13 gilteritinib
QL01EX14 entrectinib
QL01EX15 pexidartinib
QL01EX17 capmatinib
QL01EX18 avapritinib
QL01EX19 ripretinib
QL01EX21 tepotinib
QL01EX22 selpercatinib
QL01EX23 pralsetinib
QL01EX24 surufatinib
QL01EX25 umbralisib
QL01EX26 sitravatinib
QL01EX27 capivasertib
QL01EX28 repotrectinib
QL01EX90 toceranib
Last updated: 2024-12-27